Clinical trial
Zonegran for the Treatment of Weight Gain Associated With Psychotropic…
NCT00203450 · Tuscaloosa Research & Education Advancement Corporation, Other · Completed
Key facts
| NCT number | NCT00203450 |
|---|---|
| Title | Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial |
| Official title | Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial |
| Acronym | Zonegran |
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | Zonegran, Placebo |
| Enrollment | 20 |
| Start date | May 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: